Ridgeback Capital Management LLC has recently announced that it has increased stake in Affimed N.V. (NASDAQ:AFMD) by 66.83%. After grabbing 12.88 million shares, the institutional investor is now in possession of 5.16 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.63% having worth around $11.59 million. Moreover, BlackRock Fund Advisors increased its share by 18453.0 to have a control over 7.3 million shares. And Point72 Asset Management LP raised its holdings to 9207.0 shares by acquiring 4.23 million shares or 2.83% of the stake.
Affimed N.V. (AFMD) concluded trading on 05/24/23 at a closing price of $0.97, with 0.96 million shares of worth about $0.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -55.04% during that period and on Wednesday the price saw a gain of about 0.51%. Currently the company’s common shares owned by public are about 149.34M shares, out of which, 140.95M shares are available for trading.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 9 analysts are covering the AFMD stock and their offered price forecasts bring an average price target of $6.07. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $12.06 and could fall to a lowest price of $0.93. The stock’s current price level is 86.87% above of average price target set by the analysts, while a rise to estimated low would result in loss of -4.3% for the stock. However, touching the estimated high of $12.06 would mean a gain of 91.96% for the stock.
iShares Russell 2000 ETF, Pictet – Biotech, and OFE PZU Zlota Jesien are the top 3 mutual funds which are holding stakes in Affimed N.V. iShares Russell 2000 ETF is currently holding 3.12 million shares of worth totaling $2.81 million. The company recently came selling 45600.0 shares which brought its stake up to 2.09% of the company’s outstanding shares. OFE PZU Zlota Jesien, after buying 2.0 million shares, have now control over 1.34% of the stake in the company. It holds 2.0 million shares of worth $1.8 million.
However, the stock later moved at a day high price of 1.0100, or with a gain of 0.51%. Stock saw a price change of 5.39% in past 5 days and over the past one month there was a price change of 12.67%. Year-to-date (YTD), AFMD shares are showing a performance of -21.68% which decreased to -70.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.55 but also hit the highest price of $3.40 during that period. The average intraday trading volume for Affimed N.V. shares is 738.30K. The stock is currently trading 5.84% above its 20-day simple moving average (SMA20), while that difference is up 18.41% for SMA50 and it goes to -36.56% lower than SMA200.
Ridgeback Capital Management LLC acquired 12.88 million shares of Affimed N.V. having value of about $11.59 million. Data submitted at the U.S SEC by Ridgeback Capital Management LLC revealed that the firm now holds 5.16 million shares in the company valued at close to $5005688.88, or have control over 66.83% stake in the company. Affimed N.V. (NASDAQ: AFMD) currently have 149.34M outstanding shares and institutions hold larger chunk of about 66.20% of that. Holding of mutual funds in the company is about 16.14% while other institutional holders and individual stake holders have control over 29.77% and — of the stake respectively.
The stock has a current market capitalization of $129.95M and its 3Y-monthly beta is at 2.50. It has posted earnings per share of -$0.65 in the same period. It has Quick Ratio of 5.60 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AFMD, volatility over the week remained 10.23% while standing at 8.93% over the month.
Analysts are in expectations that Affimed N.V. (AFMD) stock would likely to be making an EPS of -$0.2 in the current quarter, while forecast for next quarter EPS is -$0.2 and it is -$0.72 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.25 which is -$0.12 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.13 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -25.50% while it is estimated to increase by 8.20% in next year.
Analysts at 9 brokerage firms have issued recommendations for the Affimed N.V. (AFMD)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.90. Out of those 9 Wall Street analysts, 8 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
